98 related articles for article (PubMed ID: 6437877)
21. Inhibition of ovulation in rats with epostane, an inhibitor of 3 beta-hydroxysteroid dehydrogenase.
Snyder BW; Beecham GD; Schane HP
Proc Soc Exp Biol Med; 1984 Jul; 176(3):238-42. PubMed ID: 6587400
[TBL] [Abstract][Full Text] [Related]
22. Effect of an inhibitor of 3 beta-hydroxysteroid dehydrogenase on progesterone concentrations and embryo survival in sheep.
Ashworth CJ; Wilmut I; Springbett AJ; Webb R
J Endocrinol; 1987 Feb; 112(2):205-13. PubMed ID: 3469294
[TBL] [Abstract][Full Text] [Related]
23. Effects of the 3β-hydroxysteroid dehydrogenase inhibitor trilostane on luteal progesterone production in the dog.
de Gier J; Wolthers CH; Galac S; Okkens AC; Kooistra HS
Theriogenology; 2011 Apr; 75(7):1271-9. PubMed ID: 21295836
[TBL] [Abstract][Full Text] [Related]
24. Gonadotropin versus steroid regulation of the corpus luteum of the rhesus monkey during simulated early pregnancy.
Duffy DM; Stouffer RL
Biol Reprod; 1997 Dec; 57(6):1451-60. PubMed ID: 9408254
[TBL] [Abstract][Full Text] [Related]
25. Epostane in nonpregnant females: effects on progesterone, 17 alpha-hydroxyprogesterone, and 17 beta-estradiol of two dose levels given for one month.
Rannevik G; Doeberl A; Valentin L
Fertil Steril; 1988 Dec; 50(6):893-902. PubMed ID: 3203752
[TBL] [Abstract][Full Text] [Related]
26. Effects of epostane on ovarian levels of progesterone, 17 beta-estradiol, prostaglandin E2, and prostaglandin F2 alpha during ovulation in the gonadotropin-primed immature rat.
Espey LL; Adams RF; Tanaka N; Okamura H
Endocrinology; 1990 Jul; 127(1):259-63. PubMed ID: 2361472
[TBL] [Abstract][Full Text] [Related]
27. The effect of epostane, a 3-beta hydroxy steroid dehydrogenase inhibitor, on maternal and fetal steroid levels during mid-gestation.
Selinger M; MacKenzie IZ; Gillmer MD; Phipps SL; Ferguson J
Br J Obstet Gynaecol; 1988 Jun; 95(6):596-601. PubMed ID: 3291938
[TBL] [Abstract][Full Text] [Related]
28. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
29. Effect of progesterone withdrawal in sheep during late pregnancy.
Taylor MJ; Webb R; Mitchell MD; Robinson JS
J Endocrinol; 1982 Jan; 92(1):85-93. PubMed ID: 7057124
[TBL] [Abstract][Full Text] [Related]
30. Trilostane but not prostaglandin F2alpha (PGF2alpha) or cortisol aborts 90-day-pregnant lutectomized sheep.
Weems YS; Vincent DL; Lemme C; Weems CW
Prostaglandins Other Lipid Mediat; 1999 Oct; 58(2-4):77-86. PubMed ID: 10560611
[TBL] [Abstract][Full Text] [Related]
31. Effects of steroid ablation and progestin replacement on the transcriptome of the primate corpus luteum during simulated early pregnancy.
Bishop CV; Aazzerah RA; Quennoz LM; Hennebold JD; Stouffer RL
Mol Hum Reprod; 2014 Mar; 20(3):222-34. PubMed ID: 24219889
[TBL] [Abstract][Full Text] [Related]
32. Effects on maternal and fetal steroid concentrations of induction of parturition in the sheep by inhibition of 3 beta-hydroxysteroid dehydrogenase.
Silver M
J Reprod Fertil; 1988 Mar; 82(2):457-65. PubMed ID: 2834551
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effect of synthetic progestins, 4-MA and cyanoketone on human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene-isomerase activity.
Takahashi M; Luu-The V; Labrie F
J Steroid Biochem Mol Biol; 1990 Oct; 37(2):231-6. PubMed ID: 2268554
[TBL] [Abstract][Full Text] [Related]
34. Effects of hydroxysteroid dehydrogenase inhibitors on in-vitro and in-vivo steroidogenesis in the ovine adrenal gland.
Singh-Asa P; Jenkin G; Thorburn GD
J Endocrinol; 1982 Feb; 92(2):205-12. PubMed ID: 6278042
[TBL] [Abstract][Full Text] [Related]
35. Steroid reduction during ovarian stimulation impairs oocyte fertilization, but not folliculogenesis, in rhesus monkeys.
Zelinski-Wooten MB; Hess DL; Wolf DP; Stouffer RL
Fertil Steril; 1994 Jun; 61(6):1147-55. PubMed ID: 8194632
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of primate luteal function by recombinant human chorionic gonadotropin and modulation of steroid, but not relaxin, production by an inhibitor of 3 beta-hydroxysteroid dehydrogenase during simulated early pregnancy.
Duffy DM; Hutchison JS; Stewart DR; Stouffer RL
J Clin Endocrinol Metab; 1996 Jun; 81(6):2307-13. PubMed ID: 8964869
[TBL] [Abstract][Full Text] [Related]
37. Termination of early human pregnancy with epostane.
Birgerson L; Olund A; Odlind V; Somell C
Contraception; 1987 Feb; 35(2):111-20. PubMed ID: 3595138
[TBL] [Abstract][Full Text] [Related]
38. Dissociation of relaxin and progesterone secretion from the primate corpus luteum by acute administration of a 3 beta-hydroxysteroid dehydrogenase inhibitor during the menstrual cycle.
Duffy DM; Stouffer RL; Stewart DR
Biol Reprod; 1995 Aug; 53(2):447-53. PubMed ID: 7492699
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of human placental progesterone synthesis and aromatase activity by synthetic steroidogenic inhibitors in vitro.
Rabe T; Kiesel L; Kellermann J; Weidenhammer K; Runnebaum B; Potts GO
Fertil Steril; 1983 Jun; 39(6):829-35. PubMed ID: 6574022
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of oral epostane administration to terminate pregnancy in mated laboratory bitches.
Keister DM; Gutheil RF; Kaiser LD; D'Ver AS
J Reprod Fertil Suppl; 1989; 39():241-9. PubMed ID: 2621726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
